Subscribe To
elicio therapeutics presents updated preliminary immunogenicity data from the ongoing phase 1 study of eli-002 and new preclinical data on eli-007 and eli-008 at the society for immunotherapy of cance
In patients with high relapse risk mKRAS-driven pancreatic and colorectal cancers who were given ELI-002 2P, an investigational therapeutic cancer vac...
November 3, 2023, 8:30 pm
elicio therapeutics presents updated preliminary immunogenicity data from the ongoing phase 1 study of eli-002 and new preclinical data on eli-007 and eli-008 at the society for immunotherapy of cance
In patients with high relapse risk mKRAS-driven pancreatic and colorectal cancers who were given ELI-002 2P, an investigational therapeutic cancer vac...
November 3, 2023, 8:30 pm
3 restaurant stocks that will be delicious buys this holiday season
The holiday has always been a time for reflection, celebration and gratitude for Americans. This is also a time when investors can buy restaurant stoc...
November 2, 2023, 7:09 pm
3 stocks to skip despite their delicious dividend yields
High dividend yields don't always make stocks attractive for investors. Often, stocks with high dividend yields can represent some of the worst invest...
October 26, 2023, 9:16 am
7 delicious dividend tech stocks for long-term investors
While investors favor technology stocks for their growth, they can also be a reliable source of dividend income. Dividend tech stocks offer investors ...
October 12, 2023, 5:41 pm
Clean beef firm sees gold in waste streams
Source: Streetwise Reports (9/27/23) Consumers love beef, but producing this delicious meat at scale ca...
September 29, 2023, 3:35 pm
elicio therapeutics presents updated preliminary data including promising relapse-free survival data from the phase 1 study of eli-002 at aacr special conference: pancreatic cancer
ELI-002 2P is an investigational therapeutic cancer vaccine targeting solid tumors driven by G12D and G12R mutations in KRAS As of the April 25, 2023 ...
September 27, 2023, 9:30 pm
The bloc welcomes bellalina gelato to downtown los angeles
Downtown LA, California, Aug. 08, 2023 (GLOBE NEWSWIRE) — The Bloc is introducing a new and delicious...
August 8, 2023, 11:44 pm
elicio therapeutics announces positive interim data from the phase 1 study of an investigational therapeutic cancer immunotherapy, eli-002, in patients with high relapse risk pancreatic and colorectal
ELI-002 was shown to be well-tolerated with no dose limiting toxicity or cytokine release syndrome A high proportion of patients had tumor biomarker r...
June 3, 2023, 1:00 pm
elicio therapeutics announces positive interim data from the phase 1 study of an investigational therapeutic cancer immunotherapy, eli-002, in patients with high relapse risk pancreatic and colorectal
ELI-002 was shown to be well-tolerated with no dose limiting toxicity or cytokine release syndrome A high proportion of patients had tumor biomarker r...
June 3, 2023, 1:00 pm
elicio therapeutics announces positive interim data from the phase 1 study of an investigational therapeutic cancer immunotherapy, eli-002, in patients with high relapse risk pancreatic and colorectal
ELI-002 was shown to be well-tolerated with no dose limiting toxicity or cytokine release syndrome A high proportion of patients had tumor biomarker r...
June 3, 2023, 1:00 pm
elicio therapeutics announces positive interim data from the phase 1 study of an investigational therapeutic cancer immunotherapy, eli-002, in patients with high relapse risk pancreatic and colorectal
ELI-002 was shown to be well-tolerated with no dose limiting toxicity or cytokine release syndrome A high proportion of patients had tumor biomarker r...
June 3, 2023, 1:00 pm
elicio therapeutics announces positive interim data from the phase 1 study of an investigational therapeutic cancer immunotherapy, eli-002, in patients with high relapse risk pancreatic and colorectal
ELI-002 was shown to be well-tolerated with no dose limiting toxicity or cytokine release syndrome A high proportion of patients had tumor biomarker r...
June 3, 2023, 1:00 pm
elicio therapeutics reports inducement grant to new chief financial officer
BOSTON, June 02, 2023 (GLOBE NEWSWIRE) — elicio Therapeutics (Nasdaq: ELTX), a clinical-stage biotech...
June 2, 2023, 8:30 pm
These 2 fast food stocks look delicious in a recession year
It's hard to say when or if we'll fall from an economic downturn to a full-blown recession. Treasury Secretary Janet Yellen says the economy is "stron...
May 9, 2023, 10:55 am
7 stocks to avoid at all costs despite their delicious dividend yield
In certain circumstances, high-yield dividend stocks can be great opportunities. However, often, they are well within the “stocks to avoid” catego...
April 25, 2023, 6:30 am
Angion (angn) down on merger agreement with private biotech
Angion (ANGN) inks a definitive merger agreement with privately-held elicio Therapeutics. The combined ...
January 18, 2023, 2:18 pm
Hormel foods - not too delicious
Hormel Foods Corporation was a growth darling in the 2010s, but it has suffered stagnating sales and earnings in recent years. A premium valuation for...
December 28, 2022, 4:10 pm
Orchid island capital: delicious 20% yielder with a side order of risks
ORC has low institutional investments and has failed to achieve any price growth despite delivering extremely strong yield. ORC has an option of chang...
August 22, 2022, 11:57 am
Own the hospital with medical properties reit 7.5% yield
Medical Properties Trust is a REIT which owns over 400 healthcare properties globally. The REIT pays a delicio...
July 16, 2022, 7:48 am
